[Pharmacodynamic study of a new antiasthmatic drug. Salbutamol].
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology*; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D001986:Bronchial Spasm / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002082:Butylamines / Q000494:pharmacology; D002319:Cardiovascular System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D004064:Digestive System / Q000187:drug effects; D004285:Dogs; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D007545:Isoproterenol / Q000494:pharmacology; D051379:Mice; D010627:Phenethylamines / Q000494:pharmacology; D011817:Rabbits; D012119:Respiration / Q000187:drug effects; D013566:Sympathomimetics / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D000605:Amino Alcohols; D001993:Bronchodilator Agents; D002082:Butylamines; D010627:Phenethylamines; D013566:Sympathomimetics; D007545:Isoproterenol
Etude pharmacodynamique d'un nouvel antiasthmatique. Le Salbutamol.